Cepeda M S, Uribe C, Betancourt J, Rugeles J, Carr D B
Department of Anesthesia, San Ignacio Hospital, Bogotá, Columbia.
Reg Anesth. 1997 May-Jun;22(3):233-8. doi: 10.1016/s1098-7339(06)80007-6.
This investigation was undertaken to compare analgesic effects, side effects, and requirements for supplemental analgesic therapy after knee arthroscopy in patients given intra-articular (IA) or subcutaneous (SC) morphine, intra-articular bupivacaine, or placebo.
In a randomized, double-blind controlled trial, 112 patients, 14-65 years old each received two solutions, one SC and the other IA. Group IAM (n = 30) received 10 mg IA morphine in 20 mL normal saline plus 1 mL of SC normal saline Group IAB (n = 27) received 20 mL IA bupivacaine 0.5% with IA epinephrine plus 1 mL SC normal saline Group SCM (n = 26) received 20 mL IA normal saline plus 10 mg SC morphine in 1 mL. Group P (n = 29) received 20 mL IA normal saline plus 1 mL SC normal saline. Pain was evaluated on arrival in the postanesthesia care unit (PACU), and 30, 45, 60, 90, and 120 minutes afterwards. If pain exceeded 4/10 on a visual analog pain scale in the PACU, 30 mg intravenous ketorolac was given, and if pain persisted, 0.4 mg hydromorphone was added every 7 minutes. After PACU discharge, patients whose pain exceeded 4/10 received oral ketorolac 10 mg every 6 hours; oral acetaminophen plus codeine was added every 4 hours if pain still exceeded 4/10. Analgesic requirements, along with visual analog pain score, sedation, and nausea were recorded every 6 hours for 72 hours.
All three active (nonplacebo) pain treatments provided good pain control in the PACU. Side effects were similar in all groups. The placebo group had higher pain scores at 120 minutes (R = .02), higher supplemental analgesic requirements at 60 minutes (P = .04) and 90 minutes (P = .02) and the highest amount of total opioid rescue dose (P = .04). Patients in groups IAB and P had higher visual analog pain scores at 6 hours (P = .04) and 30 hours (P = .049) than those in Groups IAM and SCM.
A single 10-mg dose of morphine given either IA or SC provides better and longer-lasting postoperative pain relief after knee arthroscopy than 20 mL IA bupivacaine 0.5% with epinephrine.
本研究旨在比较关节内(IA)或皮下(SC)注射吗啡、关节内注射布比卡因或安慰剂后,膝关节镜检查患者的镇痛效果、副作用及补充镇痛治疗的需求。
在一项随机、双盲对照试验中,112例年龄在14至65岁的患者,每人接受两种溶液,一种皮下注射,另一种关节内注射。IAM组(n = 30)接受20 mL生理盐水中含10 mg关节内吗啡加1 mL皮下注射生理盐水;IAB组(n = 27)接受20 mL含肾上腺素的0.5%关节内布比卡因加1 mL皮下注射生理盐水;SCM组(n = 26)接受20 mL关节内生理盐水加1 mL中含10 mg皮下注射吗啡;P组(n = 29)接受20 mL关节内生理盐水加1 mL皮下注射生理盐水。在进入麻醉后护理单元(PACU)时以及之后的30、45、60、90和120分钟对疼痛进行评估。如果在PACU中视觉模拟疼痛量表上疼痛超过4/10,给予30 mg静脉注射酮咯酸,如果疼痛持续,每7分钟加用0.4 mg氢吗啡酮。PACU出院后,疼痛超过4/10的患者每6小时口服10 mg酮咯酸;如果疼痛仍超过4/10,每4小时加用口服对乙酰氨基酚加可待因。每6小时记录一次镇痛需求以及视觉模拟疼痛评分、镇静情况和恶心情况,共记录72小时。
所有三种有效的(非安慰剂)疼痛治疗在PACU中均提供了良好的疼痛控制。所有组的副作用相似。安慰剂组在120分钟时疼痛评分更高(R = 0.02),在60分钟(P = 0.04)和90分钟(P = 0.02)时补充镇痛需求更高,且总阿片类药物挽救剂量最高(P = 0.04)。IAB组和P组患者在6小时(P = 0.04)和30小时(P = 0.049)时的视觉模拟疼痛评分高于IAM组和SCM组。
膝关节镜检查后,关节内或皮下注射单次10 mg吗啡比20 mL含肾上腺素的0.5%关节内布比卡因能提供更好、更持久的术后疼痛缓解。